Emmes Corporation

30 articles about Emmes Corporation

• Matt Bond Has Joined Emmes as Chief Financial Officer

  10/3/2023

  Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that Matt Bond has become its chief financial officer.

• Emmes Appoints Peter Ronco as Chief Executive Officer

  9/20/2023

  Emmes today announced that Peter Ronco has been named Chief Executive Officer, effective immediately.

• Emmes Hires Becky Marson as Chief People and Performance Officer

  4/3/2023

  Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that Becky Marson has joined the company as its chief people and performance officer.

• Emmes Acquires Essex Management

  3/21/2023

  Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced the acquisition of Essex Management.

• Emmes Supports Groundbreaking Anal Cancer Study Sponsored by the National Cancer Institute

  6/16/2022

  Emmes announced that a team of its researchers contributed to a successful AIDS Malignancy Consortium study.

• Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa

  5/16/2022

  Emmes announced that it is providing data, statistical analysis, and project management support for new research that will test the Moderna mRNA vaccine at more than 50 sites in South and East Africa.

• Emmes Acquires Institut Dr. Schauerte, Entering Real World Evidence Market

  12/21/2021

  Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company of Behrman Capital, announced that it has acquired Institut Dr. Schauerte, a CRO headquartered in Munich, Germany.

• Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research

  11/15/2021

  Emmes today announced a partnership with MedGenome aimed at accelerating breakthrough treatments, powered by human genomics, for rare disease patients.

• Emmes Standardizes on Veeva Development Cloud to Streamline Product Development

  9/21/2021

  Veeva Systems (NYSE: VEEV) today announced that Emmes is standardizing on Veeva Development Cloud applications across functional areas to enable greater speed and compliance.

• Emmes Announces New Role for the Blood and Marrow Transplant Clinical Trials Network

  8/2/2021

  Emmes today announced that it launched a new study assessing the durability of response to COVID-19 vaccinations in patients with hematological malignancies who are undergoing cellular therapies, such as blood or marrow transplantation or CAR-T infusions.

• Emmes Employees Co-Author Substance Use Article for the New England Journal of Medicine

  2/22/2021

  Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced its contribution to a study for the National Institute on Drug Abuse Clinical Trials Network and a related article published in the New England Journal of Medicine.

• Emmes Employees Contribute to New England Journal of Medicine Report on Pregnant Women with Epilepsy

  2/8/2021

  Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced the company's involvement in a recent article published in the New England Journal of Medicine.

• Paul VanVeldhuisen, Ph.D., Named President of Emmes' New Public Sector Group

  1/11/2021

  Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that long-time employee, Dr. Paul VanVeldhuisen, has been named President of Emmes Public Sector.

• Emmes Selected as Corporate Achievement Award Winner by the Montgomery County Chamber of Commerce

  10/29/2020

  Emmes announced that the Montgomery County Chamber of Commerce has selected Emmes as the recipient of its 2020 Corporate Achievement Award.

• Jonathan DeCarlo Named Chief Financial Officer at Emmes

  9/1/2020

  Emmes announced that Jonathan DeCarlo has been promoted to chief financial officer.

• Emmes Promotes Three VPs to Officer Positions

  8/6/2020

  Emmes announced that three corporate vice presidents have been promoted. Dr. Traci Clemons has been named chief research officer, Marian Ewell is now chief scientific innovation officer, and Jennifer Hester is the company's chief human resources officer.

• Emmes Chosen as a Top Area Workplace

  6/17/2020

  Emmes announced that it was selected as one of the best places to work in the greater Washington area.

• Emmes Announces its Contribution to NIH ACTT Clinical Trial for Remdesivir

  5/26/2020

  Emmes today announced that its data and statistical analysis work for the Adaptive COVID-19 Treatment Trial (ACTT) played an important role in the accelerated timetable to evaluate remdesivir's effectiveness in treating hospitalized CO

• Emmes Ranked as a Top Biosciences Employer in Greater Washington

  5/18/2020

  Emmes today announced that it was ranked as the seventh largest biosciences employer in the greater Washington area.  The ranking is compiled annually by the Washington Business Journal.

• Emmes Announces Dr. Joe Sliman as New Chief Medical Officer

  5/4/2020

   Emmes today announced that Dr. Joe Sliman has been named the company's chief medical officer (CMO).  According to Dr. Anne Lindblad , president and chief operating officer, "The depth and breadth of